NewLimit, a startup co-founded by Coinbase CEO Brian Armstrong, has raised $40 million in funding to research ways to reverse the aging process through epigenetics. The company aims to manipulate cells so that cells that have become "old" can flip back to a youthful state. While Armstrong did not specify how many years of life extension this research may provide, the focus is more on extending healthy years and quality of life. NewLimit's initial research will focus on T cells of the immune system. Armstrong compared NewLimit's efforts to SpaceX, noting that while the ultimate goal is ambitious, partnerships and revenue from more immediate applications can help advance the overall mission.
All Comments